Reed Tuckson joins Cell Therapeutics board
This article was originally published in Scrip
Cell Therapeutics has appointed Dr Reed Tuckson to its board of directors, increasing the overall number of board members to nine. Dr Tuckson is executive vice-president and chief of medical affairs at UnitedHealth Group, as well as a member of many committees including the Institute of Medicine of the National Academy of Sciences.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.